- Supported exchanges /
- PINK /
- SPHDF.PINK
Santhera Pharmaceuticals Holding AG (SPHDF PINK) stock market data APIs
Santhera Pharmaceuticals Holding AG, a specialty pharmaceutical company, together with its subsidiaries, develops and commercializes medicines for rare neuromuscular and pulmonary diseases with high unmet medical need in the Europe, North America, and Asia. The company's lead pipeline candidate includes Vamorolone, which is developed for the treatments of Duchenne muscular dystrophy (DMD). Its clinical stage pipeline also comprises Lonodelestat for the treatment of cystic fibrosis and other neutrophilic pulmonary diseases. Santhera Pharmaceuticals Holding AG was founded in 2004 and is headquartered in Pratteln, Switzerland.
Santhera Pharmaceuticals Holding AG Financial Data Overview
| 9.42 | |
| 9.42 | |
| - | |
| 9.42 | |
| 9.42 | |
| 9.42-11.7 | |
| 153 M | |
| 1.4719 | |
| 12 106 K | |
| 114 M | |
| -0.4985 | |
| 0.131 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
Santhera Pharmaceuticals Holding AG Fundamental Data is available in our Financial Data APIs
- Net Revenue 114 M
- EBITDA 57 274 K
- Earnings Per Share 6.4
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get Santhera Pharmaceuticals Holding AG Earnings via APIs
- Latest Release 2021-06-30
- EPS/Forecast 0
Get Santhera Pharmaceuticals Holding AG End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
